The unfinished business of U.S. drug safety regulation
Affiliations
- PMID: 16838457
Item in Clipboard
The unfinished business of U.S. drug safety regulation
Food Drug Law J.
2006.
No abstract available
Similar articles
-
Industry reneges on postmarketing trial commitments.Nat Biotechnol. 2003 Jul;21(7):718. doi: 10.1038/nbt0703-718. Nat Biotechnol. 2003. PMID: 12833074 No abstract available.
-
U.S. postmarketing pharmacovigilance compliance in the midst of regulatory uncertainty.Food Drug Law J. 2007;62(3):513-28. Food Drug Law J. 2007. PMID: 17915393 No abstract available.
-
FDA attempting to overcome major roadblocks in monitoring drug safety.J Natl Cancer Inst. 2005 Jun 15;97(12):872-3. doi: 10.1093/jnci/97.12.872. J Natl Cancer Inst. 2005. PMID: 15956645 No abstract available.
-
Food and Drug Administration regulation and evaluation of vaccines.Pediatrics. 2011 May;127 Suppl 1:S23-30. doi: 10.1542/peds.2010-1722E. Epub 2011 Apr 18. Pediatrics. 2011. PMID: 21502242 Review.
-
Regulatory considerations for determining postmarketing study commitments.Clin Pharmacol Ther. 2007 Aug;82(2):228-30. doi: 10.1038/sj.clpt.6100238. Epub 2007 May 30. Clin Pharmacol Ther. 2007. PMID: 17538552 Review.
Cited by
-
Creating and evaluating genetic tests predictive of drug response.Nat Rev Drug Discov. 2008 Jul;7(7):568-74. doi: 10.1038/nrd2520. Epub 2008 Jun 20. Nat Rev Drug Discov. 2008. PMID: 18587383 Free PMC article. Review.
-
The value of using top-down and bottom-up approaches for building trust and transparency in biobanking.Public Health Genomics. 2010;13(4):207-14. doi: 10.1159/000279622. Epub 2010 Apr 15. Public Health Genomics. 2010. PMID: 20395689 Free PMC article.
MeSH terms
LinkOut - more resources
Medical